Research

Take our Survey and help us improve surveillance in Kidney Cancer

Help us improve surveillance in kidney cancer by taking the KCCure kidney cancer survey

KCCure Co-founder Susan Poteat presents to IKCC in Poland

It's hard to believe how far we've come as an organization in less than one year since our launch.  This week, marked another milestone as KCCure was represented, for the first time, at the International Kidney Cancer Coalition Conference (IKCC) in Warsaw, Poland.

Report from ASCO GU 2017

ASCO GU is an annual symposium where doctors and members of the cancer community gather from around the world to discuss the latest and greatest in research for Genitourinary (GU) Cancers – which includes kidney cancer.  KCCure was honored to be included, along with many other valued advocacy organizations, representing the patient voice.

KCCure interviews Dr. Mike Atkins about the TIVO-3 trial

KCCure talks with Dr. Michael Atkins, Deputy Director of the Georgetown-Lombardi Comprehensive Cancer Center in Washington, DC about the TIVO-3 trial and what it means for kidney cancer patients.

Renal Medullary Carcinoma (RMC) – Rare but not Invisible

There are rare subtypes of kidney cancer that don't get enough attention.

Of Clinical Trials and Vampires

Why do phlebotomists take all that blood after an infusion?

Kidney Cancer Oncologist Breaks the Glass Ceiling

I was thrilled to see the unexpected news that Dr. Toni Choueiri will become Director of the Genitourinary Oncology Disease Center and the Lank Center for Genitourinary Oncology.

Harnessing Immuno-therapy for Kidney Cancer

Unleashing the immune system by inhibiting its natural breaks (i.e. immune checkpoints) has started an unprecedented revolution in kidney cancer immunotherapy treatment.

  • 1
  • 2

Lost Password

Register

Subscribe for updates!